Haleon plc

NYSE:HLN

Drug Manufacturers - Specialty & Generic

Healthcare
$9.08 +0.96%

+$0.08 today

Market cap
$39.85B
Beta
0.25
P/E (TTM)
29.2
EPS (TTM)
$0.11
Dividend yield
2.13%
52W Low $8.65High $11.28

Volume 19.46M

Average 8.79M

HLN Net Income

Bottom-line profit after all expenses, interest, and taxes.

Haleon plcNYSE: HLN

Net Income · Q4 FY2025 · quarter ended Dec 2025

Net income grows 19.5% year over year

Q4 FY2025 net income of £855.69M rose 19.5% year over year. Over 3 fiscal years it compounded at +15.4% a year.

Context

  • Net income amounted to 14.8% of revenue in FY2025, up 1.9 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 12 analysts of £1.89B (+15.7%) for the fiscal year ending Dec 2026, a step up from the +13.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
£855.69M— QoQ
Last fiscal yearDec 2025
£1.63B+13.1% YoY
LTMJun 2025
£2.41B— YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.5%+87.7%+68.2 pp
1 year+13.1%+15.7%+2.6 pp
3-year CAGR+15.4%+9.7%-5.7 pp
5-year CAGR+8.9%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

GBP · from the income statement

Latest · FY2025
1.63B GBP
Year-over-year change
+13.1%
4-year CAGR
+4.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How HLN compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Net income amounts to 14.6% of revenue for HLN, versus a peer median of 12.4%.
HLN Competitors
Net Income for HLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GSKGSK plcLTM Jun 2026£4.82B GBP+40.8%-27.4%14.5%
HLNHaleon plcLTM Jun 2025£2.41B GBP—+15.4%14.6%
CLColgate-Palmolive CompanyLTM Sep 2026$2.05B USD-29.4%+6.1%9.6%
KVUEKenvue Inc.LTM Sep 2026$1.69B USD+17.9%-10.7%10.9%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$774.8M USD-1.0%+21.2%12.4%
PRGOPerrigo Company plcLTM Jun 2026-$1.73B USD-2060.3%—41.9%
Peer median (excluding HLN) —-1.0%-2.3%12.4%

Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.55B10.86B11.3B11.23B11.03B
Cost of Revenue3.6B4.28B4.34B4.29B3.83B
Gross Profit5.95B6.58B6.96B6.95B6.99B
Gross Margin62.3%60.6%61.6%61.9%63.3%
Research & Development257M300M311M298M308.1M
Selling, General & Admin3.79B4.04B4.29B4.33B4.36B
Operating Expenses4.31B4.75B4.97B4.74B4.43B
Depreciation & Amortization268M287M309M196M352.11M
EBITDA2.21B2.18B2.35B2.51B2.88B
EBITDA Margin23.2%20.1%20.8%22.4%26.1%
Operating Income1.64B1.83B2B2.21B2.41B
Operating Margin17.2%16.8%17.7%19.6%21.9%
Interest Income13M68.98M14M55M76.29M
Interest Expense16M347.36M414M394M332.55M
Other Income / Expenses(2M)(207M)(368M)(296M)(260M)
Income Before Tax1.64B1.62B1.63B1.91B2.15B
Pre-Tax Margin17.1%14.9%14.4%17.0%19.5%
Income Tax Expense197M499M517M435M461.66M
Net Income1.39B1.06B1.05B1.44B1.63B
Net Margin14.6%9.8%9.3%12.8%14.8%
EPS (Basic)0.300.240.240.320.36
EPS (Diluted)0.300.240.240.320.36
Weighted Avg Shares4.62B4.62B4.63B4.57B4.48B
Weighted Avg Shares (Diluted)4.62B4.62B4.63B4.59B4.51B

Haleon plc

NYSE:HLN

Intrinsic Alpha fair value

Locked

Current Price

$9.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.